Pharmaceutical prices vary wildly across countries due to policy, not cost. The U.S. pays far more for brand-name drugs but less for generics. Japan and France have the lowest prices. Medicare's new negotiation powers could change the game in 2025.
Crossover trial design is the standard method for bioequivalence studies, allowing regulators to compare generic and brand-name drugs using each participant as their own control. It reduces sample size, improves accuracy, and is required for most generic drug approvals.
Crohn's disease and ulcerative colitis are two distinct forms of inflammatory bowel disease. Learn how they differ in location, depth of inflammation, complications, treatment, and long-term outcomes.
Fasted and fed state testing reveal how food impacts drug absorption and exercise performance. Understanding both conditions helps ensure medications work properly and training delivers real results.
Osteoporosis isn't just about aging bones-it's about preventable fractures. Learn how calcium, vitamin D, exercise, and lifestyle choices can stop bone loss and keep you from breaking a bone.
Personal stories shape how patients accept generic medications more than science alone. Narrative medicine helps both patients and doctors understand these hidden emotional narratives to improve adherence and trust in treatment.
Learn how bracing, injections, and exercise work together to manage knee osteoarthritis pain without surgery. Discover what really works, what to avoid, and how to build a plan that lasts.
Learn practical, science-backed ways to reduce allergens in your home-from dust mites and pet dander to mold and cockroaches. These environmental control strategies can cut allergy symptoms without relying solely on medication.
Bisphosphonates help prevent osteoporosis fractures, but they only work if taken correctly with calcium. Timing matters-take them on an empty stomach, wait an hour before calcium, and never mix them. Here's how to get it right.
Modern bioequivalence studies must account for age and sex differences to ensure generic drugs work safely for everyone. Learn what the FDA, EMA, and other regulators require today-and why outdated study designs are no longer enough.